Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-06-04

Clinical Trial Update: Chemotherapy With or Without Immune Checkpoint Inhibitors for Lung Cancer

View source ↗

Summary

A clinical trial is evaluating whether adding immune checkpoint inhibitors to chemotherapy improves outcomes in non-small cell lung cancer. The study is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chemotherapy (chemotherapy)
  • Immune checkpoint inhibitors (immune checkpoint inhibitor)

Snippet

Sponsor: Hunan Province Tumor Hospital | Conditions: Non Small Cell Lung Cancer | Status: RECRUITING